Bildkälla: Stockfoto

Active Biotech: Tasquinimod in Expansion Cohort in MM - Redeye

Redeye comments on tasquinimod’s advancement into the phase IIa part in multiple myeloma.

Redeye comments on tasquinimod’s advancement into the phase IIa part in multiple myeloma.
Börsvärldens nyhetsbrev
ANNONSER